Hawaii Senate bill in Session 2026.
Status: failed. Latest action: February 10, 2025.
Department of Health; Affordable Health Care; Prescription Drugs; 340B Drug Pricing Program; Pharmacies; Covered Entities; Discriminatory Practices.
Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.
| Date | Event | Detail |
|---|---|---|
| 0000-00-00 | Introduced | Bill introduced |
| 2025-02-10 | Status | failed |
| 2025-02-10 | Latest Action | The committee on HHS deferred the measure. |